Wockhardt Limited — Others, 14-05-2025: Monitoring Agency Report

Wockhardt Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company confirmed full utilization of funds from its first QIP of ₹480.04 crore across debt repayment, clinical trials, R&D, working capital, and corporate purposes. The second QIP of ₹1,000 crore is partly utilized, mainly for debt repayment, capital expenditure, R&D, and corporate needs, with remaining funds invested in mutual funds and fixed deposits. This prudent fund management reinforces Wockhardt’s operational growth and financial stability.